POU5F1 and urinary bladder carcinoma: Given the complexity and heterogeneity of bladder cancer as well as the variety of mechanisms involved in drug resistance, further studies are warranted to uncover the molecular basis by which Oct4 induces acquired resistance of bladder cancer to different anticancer drugs.